Evidence map›Paper›PMID 31367681›Full record

ArticleDiagnostic and prognostic research2019

A comparison of landmark methods and time-dependent ROC methods to evaluate the time-varying performance of prognostic markers for survival outcomes.

Aasthaa Bansal, Patrick J Heagerty

Abstract read
In one paragraph

Article in Diagnostic and prognostic research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Cardiac fibrosis as a predictor for sudden cardiac death after transcatheter aortic valve implantation.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aasthaa Bansal1The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, H-375 Health Sciences Building, Campus Mail Stop 357630, Seattle, 98195 WA USA.ORCID 0000-0001-5507-2640
Patrick J Heagerty2Department of Biostatistics, University of Washington, F-600 Health Sciences Building, Campus Mail Stop 357232, Seattle, 98195 WA USA.

Funding

Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISER37CA218413 · NCI · UNIVERSITY OF WASHINGTON · PI BANSAL, AASTHAA · 2018 to 2024
$3.0M
NCI NIH HHS R37 CA218413
6 · The paper itself

Abstract

backgroundPrognostic markers use an individual's characteristics at a given time to predict future disease events, with the ultimate goal of guiding medical decision-making. If an accurate prediction can be made, then a prognostic marker could be used clinically to identify those subjects at greatest risk for future adverse events and may be used to define populations appropriate for targeted therapeutic intervention. Often, a marker is measured at a single baseline time point such as disease diagnosis, and then used to guide decisions at multiple subsequent time points. However, the performance of candidate markers may vary over time as an individual's underlying clinical status changes.

methodsWe provide an overview and comparison of modern statistical methods for evaluating the time-varying accuracy of a baseline prognostic marker. We compare approaches that consider cumulative versus incident events. Additionally, we compare the common approach of using hazard ratios obtained from Cox proportional hazards regression to more recently developed approaches using time-dependent receiver operating characteristic (ROC) curves. The alternative statistical summaries are illustrated using a multiple myeloma study of candidate biomarkers.

resultsWe found that time-varying HRs, HR (

conclusionsWe compared alternative summaries for quantifying a prognostic marker's time-varying performance. Although landmark-based predictions may be useful when patient predictions are needed at select times, a focus on incident events naturally facilitates evaluating trends in performance over time.

Indexed as

BiomarkersHazard ratioMedical decision-makingPrognosisROC curve

Identifiers

PMID31367681
PMCPMC6657082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.